3 Clinical-Stage Biotech Stocks with Explosive Upside Potential in 2015
Clinical-stage biotechs tend to bubble to the top of the list of best performing healthcare stocks. Here are three names to watch in 2015 and beyond.
Cancel JPMorgan! Plenty of Pre-Conference Data and Deals to Digest
The week before JPMorgan Healthcare conference brought a plethora of deals and data.
2015 Dogs of the Dow: 10 Dividend Stocks You Should Watch This Year
This popular strategy is easy to follow and generates solid dividend income.
Does AstraZeneca PLC Stock Offer a Golden Opportunity in 2015?
AstraZeneca would appear to be set to have a slow 2015. But that doesn't mean investors should sleep on this stock. Here's why.
Is Gilead Sciences Inc. Now a Takeover Target?
Gilead Sciences looks cheap based on its present valuation metrics and growth prospects going forward. Will a growth-starved big pharma decide to pursue a merger with this high flying biotech in 2015?